Skip to main content
Fig. 4 | BMC Infectious Diseases

Fig. 4

From: Kinetics of adaptive immune responses after administering mRNA-Based COVID-19 vaccination in individuals with and without prior SARS-CoV-2 infections

Fig. 4

Neutralizing activity in individuals with or without prior SARS-CoV-2 infections. (a) representing neutralizing activity against the Wuhan strain, (b) against the Delta variant, and (c) against the Omicron variant. The upper panel represents the plaque reduction from each serum dilution. The lower panel demonstrates the PRNT50 titer

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us